Difference between revisions of "Sekulic A, et al. N. Engl. J. Med. (2012) cited as Ref 599 in DOI: 10.1038/s41392-020-0110-5 (Q9862)"
Jump to navigation
Jump to search
(Created claim: First Author string (P149): Sekulic A, #quickstatements; #temporary_batch_1589996169159) |
(Created claim: DOI Identifier (P138): 10.1056/NEJMoa1113713, #quickstatements; #temporary_batch_1590000649558) |
||
Property / DOI Identifier | |||
+ | |||
Property / DOI Identifier: 10.1056/NEJMoa1113713 / rank | |||
+ | Normal rank |
Revision as of 19:03, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language | Label | Description | Also known as |
---|---|---|---|
English |
Sekulic A, et al. N. Engl. J. Med. (2012) cited as Ref 599 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Sekulic A
0 references